NCT01720563 2025-06-04
A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy
PhytoHealth Corporation
Phase 2 Terminated
PhytoHealth Corporation
Royal Marsden NHS Foundation Trust
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Northwestern University